These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 3802379)

  • 1. Clinical pharmacology of the biological response modifier maleic anhydride divinyl ether copolymer (MVE-2).
    Rosenblum MG; Rios AM; Hersh EM
    Cancer Chemother Pharmacol; 1986; 18(3):243-6. PubMed ID: 3802379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell and tissue distribution of 14C-labeled pyran copolymer.
    Papamatheakis JD; Schultz RM; Chirigos MA; Massicot JG
    Cancer Treat Rep; 1978 Nov; 62(11):1845-51. PubMed ID: 728902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship of molecular weight to antiviral and antitumor activities and toxic effects of maleic anhydride-divinyl ether (MVE) polyanions.
    Morahan PS; Barnes DW; Munson AE
    Cancer Treat Rep; 1978 Nov; 62(11):1797-803. PubMed ID: 103618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo modulation of myelopoiesis and immune functions by maleic anhydride divinyl ether copolymer (MVE-2) in tumor-free and MBL-2 tumor-bearing mice treated with cyclophosphamide.
    Schlick E; Ruffmann R; Chirigos MA; Welker RD; Herberman RB
    Cancer Res; 1985 Mar; 45(3):1108-14. PubMed ID: 3871661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of the biological response modifier MVE-2 (AD-022) in biological fluids by high-performance liquid chromatography.
    Rosenblum MG; Hersh EM; Loo TL
    J Chromatogr; 1983 Jan; 272(1):200-4. PubMed ID: 6841541
    [No Abstract]   [Full Text] [Related]  

  • 6. Therapy of artificial and spontaneous metastases of murine tumors with maleic anhydride-divinyl ether-2.
    Milas L; Hersh EM; Hunter N
    Cancer Res; 1981 Jun; 41(6):2378-85. PubMed ID: 7237436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maleic vinyl ether anhydride nephropathy: altered glomerular permeability due to an immunomodulating agent.
    Bertolatus JA
    Clin Immunol Immunopathol; 1988 Oct; 49(1):6-18. PubMed ID: 2842098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of mammary and urinary bladder carcinogenesis by a retinoid and a maleic anhydride-divinyl ether copolymer (MVE-2).
    McCormick DL; Becci PJ; Moon RC
    Carcinogenesis; 1982; 3(12):1473-6. PubMed ID: 6217919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced incidence of rat colon cancer metastases by perioperative immunostimulation with maleic anhydride-divinyl ether-2 (MVE-2).
    Weese JL; Gilbertson EM; Syrjala SE; Whitney PD; Starling JR
    Dis Colon Rectum; 1985 Apr; 28(4):217-21. PubMed ID: 3979221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunomodulation and antitumor effects of MVE-2 in mice.
    Talmadge JE; Maluish AE; Collins M; Schneider M; Herberman RB; Oldham RK; Wiltrout RH
    J Biol Response Mod; 1984 Dec; 3(6):634-52. PubMed ID: 6334720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the immunological and toxicological properties of MVE-2 in phase I trials.
    Rinehart JJ; Young DC; Neidhart JA
    Cancer Res; 1983 May; 43(5):2358-62. PubMed ID: 6831459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pinocytic uptake of divinyl ether-maleic anhydride (pyran copolymer) and its failure to stimulate pinocytosis.
    Pratten MK; Duncan R; Cable HC; Schnee R; Ringsdorf H; Lloyd JB
    Chem Biol Interact; 1981 Jun; 35(3):319-30. PubMed ID: 7226278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bimodal effects of MVE-2 on cytotoxic activity of natural killer cell and macrophage tumoricidal activities.
    Piccoli M; Saito T; Chirigos MA
    Int J Immunopharmacol; 1984; 6(6):569-76. PubMed ID: 6511143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inability of anti-asialo-GM1 and 2-chloroadenosine to abrogate maleic anhydride-divinyl ether-induced resistance against experimental murine lung carcinoma metastases.
    Schultz RM; Tang JC; DeLong DC; Ades EW; Altom MG
    Cancer Res; 1986 Nov; 46(11):5624-8. PubMed ID: 3756909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase I study of MVE-2 evaluating toxicity and biologic response modification capability.
    Hainsworth JD; Forbes JT; Grosh WW; Greco FA
    Cancer Immunol Immunother; 1986; 22(1):68-71. PubMed ID: 2423241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pyran copolymer: effect of molecular weight on stem cell mobilization in mice.
    Zander AR; Spitzer G; Verma DS; Ginzbarg S; Dicke KA
    Biomedicine; 1980 May; 33(3):69-72. PubMed ID: 7448325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimetastatic effects of maleic anhydride-divinyl ether in rats with mammary adenocarcinoma.
    Khato J; Chirigos MA; Sieber SM
    J Immunopharmacol; 1983; 5(1-2):65-75. PubMed ID: 6655251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody-independent protection in mice against type Ia group B streptococcus lethal infection.
    Scaringi L; Tissi L; Cornacchione P; Rosati E; Campanelli C; von Hunolstein C; Orefici G; Rossi R; Marconi P
    FEMS Immunol Med Microbiol; 1994 Aug; 9(2):151-62. PubMed ID: 7804166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase I study of MVE-2 therapy in human cancer.
    Rios A; Rosenblum M; Powell M; Hersh E
    Cancer Treat Rep; 1983 Mar; 67(3):239-43. PubMed ID: 6831471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Responsiveness of the Madison 109 lung carcinoma to maleic vinyl ether copolymer.
    Klykken PC; Loveless SE; Morahan PS; Munson AE
    J Immunopharmacol; 1983; 5(1-2):31-47. PubMed ID: 6655250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.